EXAGEN INC. - COMMON STOCK

5.7100

09-May-25 15:45:00

15 minutes delayed

Stocks

-0.4500

-7.31%

Today's range

5.5100 - 6.2578

ISIN

N/A

Source

NASDAQ

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021

02 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
Exagen Inc. to Participate in the Cowen 41st Annual Health Care Conference

22 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

03 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

21 Jan 2021 15:05:00 By Nasdaq GlobeNewswire
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results

10 Jan 2021 17:00:00 By Nasdaq GlobeNewswire
Exagen Inc. To Participate in 2021 ICR Conference

05 Jan 2021 15:05:00 By Nasdaq GlobeNewswire
Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases

04 Jan 2021 15:05:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.